CARA logo

Cara Therapeutics (CARA) Total Assets

Annual Total Assets

$125.84 M
-$56.39 M-30.94%

31 December 2023

CARA Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$51.33 M
-$21.17 M-29.20%

30 September 2024

CARA Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CARA Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-30.9%-55.5%
3 y3 years-53.6%-77.2%
5 y5 years-34.0%-80.5%

CARA Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-53.6%at low-79.2%at low
5 y5 years-53.6%at low-81.1%at low
alltimeall time-53.6%+2172.8%-81.1%+827.0%

Cara Therapeutics Total Assets History

DateAnnualQuarterly
Sept 2024
-
$51.33 M(-29.2%)
June 2024
-
$72.50 M(-19.5%)
Mar 2024
-
$90.10 M(-28.4%)
Dec 2023
$125.84 M(-30.9%)
$125.84 M(+9.1%)
Sept 2023
-
$115.34 M(-14.2%)
June 2023
-
$134.39 M(-12.3%)
Mar 2023
-
$153.28 M(-15.9%)
Dec 2022
$182.24 M(-26.2%)
$182.24 M(-14.6%)
Sept 2022
-
$213.51 M(-5.8%)
June 2022
-
$226.57 M(+1.2%)
Mar 2022
-
$223.87 M(-9.4%)
Dec 2021
$247.06 M(-8.9%)
$247.06 M(+9.8%)
Sept 2021
-
$225.09 M(+1.6%)
June 2021
-
$221.45 M(-11.5%)
Mar 2021
-
$250.23 M(-7.7%)
Dec 2020
$271.16 M(+16.4%)
$271.16 M(+84.3%)
Sept 2020
-
$147.14 M(-12.7%)
June 2020
-
$168.61 M(-14.0%)
Mar 2020
-
$196.17 M(-15.8%)
Dec 2019
$232.96 M(+22.1%)
$232.96 M(-11.7%)
Sept 2019
-
$263.80 M(+76.3%)
June 2019
-
$149.64 M(-12.3%)
Mar 2019
-
$170.59 M(-10.6%)
DateAnnualQuarterly
Dec 2018
$190.82 M(+96.7%)
$190.82 M(-10.3%)
Sept 2018
-
$212.70 M(+52.0%)
June 2018
-
$139.89 M(+73.5%)
Mar 2018
-
$80.64 M(-16.9%)
Dec 2017
$97.00 M(+52.0%)
$97.00 M(-10.2%)
Sept 2017
-
$108.05 M(-8.4%)
June 2017
-
$117.97 M(+172.5%)
Mar 2017
-
$43.30 M(-32.2%)
Dec 2016
$63.83 M(-42.4%)
$63.83 M(-20.4%)
Sept 2016
-
$80.15 M(-12.9%)
June 2016
-
$92.05 M(-9.8%)
Mar 2016
-
$102.01 M(-8.0%)
Dec 2015
$110.90 M(+98.3%)
$110.90 M(-5.9%)
Sept 2015
-
$117.90 M(+153.9%)
June 2015
-
$46.44 M(-10.1%)
Mar 2015
-
$51.65 M(-7.7%)
Dec 2014
$55.93 M(+209.3%)
$55.93 M(-10.3%)
Sept 2014
-
$62.37 M(-8.5%)
June 2014
-
$68.19 M(-4.7%)
Mar 2014
-
$71.56 M(+295.7%)
Dec 2013
$18.08 M(+226.6%)
$18.08 M(-18.1%)
Sept 2013
-
$22.07 M(+298.6%)
Dec 2012
$5.54 M(-48.2%)
$5.54 M
Dec 2011
$10.69 M
-

FAQ

  • What is Cara Therapeutics annual total assets?
  • What is the all time high annual total assets for Cara Therapeutics?
  • What is Cara Therapeutics annual total assets year-on-year change?
  • What is Cara Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Cara Therapeutics?
  • What is Cara Therapeutics quarterly total assets year-on-year change?

What is Cara Therapeutics annual total assets?

The current annual total assets of CARA is $125.84 M

What is the all time high annual total assets for Cara Therapeutics?

Cara Therapeutics all-time high annual total assets is $271.16 M

What is Cara Therapeutics annual total assets year-on-year change?

Over the past year, CARA annual total assets has changed by -$56.39 M (-30.94%)

What is Cara Therapeutics quarterly total assets?

The current quarterly total assets of CARA is $51.33 M

What is the all time high quarterly total assets for Cara Therapeutics?

Cara Therapeutics all-time high quarterly total assets is $271.16 M

What is Cara Therapeutics quarterly total assets year-on-year change?

Over the past year, CARA quarterly total assets has changed by -$64.01 M (-55.50%)